Literature DB >> 9835565

Two-component anti-Staphylococcus aureus lantibiotic activity produced by Staphylococcus aureus C55.

M A Navaratna1, H G Sahl, J R Tagg.   

Abstract

Staphylococcus aureus C55 was shown to produce bacteriocin activity comprising three distinct peptide components, termed staphylococcins C55alpha, C55beta, and C55gamma. The three peptides were purified to homogeneity by a simple four-step purification procedure that consisted of ammonium sulfate precipitation followed by XAD-2 and reversed-phase (C8 and C18) chromatography. The yield following C8 chromatography was about 86%, with a more-than-300-fold increase in specific activity. When combined in approximately equimolar amounts, staphylococcins C55alpha and C55beta acted synergistically to kill S. aureus or Micrococcus luteus but not S. epidermidis strains. The N-terminal amino acid sequences of all three peptides were obtained and staphylococcins C55alpha and C55beta were shown to be lanthionine-containing (lantibiotic) molecules with molecular weights of 3,339 and 2,993, respectively. The C55gamma peptide did not appear to be a lantibiotic, nor did it augment the inhibitory activities of staphylococcin C55alpha and/or C55beta. Plasmids of 2. 5 and 32.0 kb are present in strain C55, and following growth of this strain at elevated temperature (42 degreesC), a large proportion of the progeny failed to produce strong bacteriocin activity and also lost the 32.0-kb plasmid. Protoplast transformation of these bacteria with purified 32-kb plasmid DNA regenerates the ability to produce the strong bacteriocin activity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9835565      PMCID: PMC90925     

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  31 in total

1.  Production and properties of a staphylococcin genetically controlled by the staphylococcal plasmid for exfoliative toxin synthesis.

Authors:  M Rogolsky; B B Wiley
Journal:  Infect Immun       Date:  1977-03       Impact factor: 3.441

2.  Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa.

Authors:  H Schägger; G von Jagow
Journal:  Anal Biochem       Date:  1987-11-01       Impact factor: 3.365

3.  Demonstration of a bactericidal substance against beta-hemolytic streptococci in supernatant fluids of staphylococcal cultures.

Authors:  A S Dajani; L W Wannamaker
Journal:  J Bacteriol       Date:  1969-03       Impact factor: 3.490

4.  Kinetic studies on the interaction of bacteriophage type 71 staphylococcal bacteriocin with susceptible bacteria.

Authors:  A S Dajani; L W Wannamaker
Journal:  J Bacteriol       Date:  1973-05       Impact factor: 3.490

5.  Production, purification and chemical properties of an antistaphylococcal agent produced by Staphylococcus epidermidis.

Authors:  H G Sahl; H Brandis
Journal:  J Gen Microbiol       Date:  1981-12

6.  A simplification of the protein assay method of Lowry et al. which is more generally applicable.

Authors:  G L Peterson
Journal:  Anal Biochem       Date:  1977-12       Impact factor: 3.365

7.  Epidermin: sequencing of a heterodetic tetracyclic 21-peptide amide antibiotic.

Authors:  H Allgaier; G Jung; R G Werner; U Schneider; H Zähner
Journal:  Eur J Biochem       Date:  1986-10-01

8.  Purification and characterization of staphylococcin BacR1, a broad-spectrum bacteriocin.

Authors:  S S Crupper; A J Gies; J J Iandolo
Journal:  Appl Environ Microbiol       Date:  1997-11       Impact factor: 4.792

9.  "Fingerprinting" beta-haemolytic streptococci by their production of and sensitivity to bacteriocine-like inhibitors.

Authors:  J R Tagg; L V Bannister
Journal:  J Med Microbiol       Date:  1979-11       Impact factor: 2.472

10.  Prepeptide sequence of epidermin, a ribosomally synthesized antibiotic with four sulphide-rings.

Authors:  N Schnell; K D Entian; U Schneider; F Götz; H Zähner; R Kellner; G Jung
Journal:  Nature       Date:  1988-05-19       Impact factor: 49.962

View more
  31 in total

1.  Sequential actions of the two component peptides of the lantibiotic lacticin 3147 explain its antimicrobial activity at nanomolar concentrations.

Authors:  Sheila M Morgan; Paula M O'connor; Paul D Cotter; R Paul Ross; Colin Hill
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

2.  Overproduction of wild-type and bioengineered derivatives of the lantibiotic lacticin 3147.

Authors:  Paul D Cotter; Lorraine A Draper; Elaine M Lawton; Olivia McAuliffe; Colin Hill; R Paul Ross
Journal:  Appl Environ Microbiol       Date:  2006-06       Impact factor: 4.792

3.  Identification of a novel two-peptide lantibiotic, lichenicidin, following rational genome mining for LanM proteins.

Authors:  Máire Begley; Paul D Cotter; Colin Hill; R Paul Ross
Journal:  Appl Environ Microbiol       Date:  2009-06-26       Impact factor: 4.792

4.  Investigating the importance of charged residues in lantibiotics.

Authors:  Srinivas Suda; Colin Hill; Paul D Cotter; R Paul Ross
Journal:  Bioeng Bugs       Date:  2010 Sep-Oct

Review 5.  Mechanistic Understanding of Lanthipeptide Biosynthetic Enzymes.

Authors:  Lindsay M Repka; Jonathan R Chekan; Satish K Nair; Wilfred A van der Donk
Journal:  Chem Rev       Date:  2017-01-30       Impact factor: 60.622

Review 6.  Targeting the Achilles' Heel of Bacteria: Different Mechanisms To Break Down the Peptidoglycan Cell Wall during Bacterial Warfare.

Authors:  Stephanie Sibinelli-Sousa; Julia Takuno Hespanhol; Ethel Bayer-Santos
Journal:  J Bacteriol       Date:  2021-03-08       Impact factor: 3.490

7.  Production of the Bsa lantibiotic by community-acquired Staphylococcus aureus strains.

Authors:  Karen M Daly; Mathew Upton; Stephanie K Sandiford; Lorraine A Draper; Philip A Wescombe; Ralph W Jack; Paula M O'Connor; Angela Rossney; Friedrich Götz; Colin Hill; Paul D Cotter; R Paul Ross; John R Tagg
Journal:  J Bacteriol       Date:  2009-12-18       Impact factor: 3.490

8.  Isolation and identification of a Paenibacillus polymyxa strain that coproduces a novel lantibiotic and polymyxin.

Authors:  Zengguo He; Duygu Kisla; Liwen Zhang; Chunhua Yuan; Kari B Green-Church; Ahmed E Yousef
Journal:  Appl Environ Microbiol       Date:  2006-10-27       Impact factor: 4.792

9.  Dissecting structural and functional diversity of the lantibiotic mersacidin.

Authors:  Antony N Appleyard; Shaila Choi; Daniel M Read; Ann Lightfoot; Steven Boakes; Anja Hoffmann; Ian Chopra; Gabriele Bierbaum; Brian A M Rudd; Michael J Dawson; Jesus Cortes
Journal:  Chem Biol       Date:  2009-05-29

10.  Insights into the mode of action of the two-peptide lantibiotic haloduracin.

Authors:  Trent J Oman; Wilfred A van der Donk
Journal:  ACS Chem Biol       Date:  2009-10-16       Impact factor: 5.100

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.